FIELD: medicine, veterinary science.
SUBSTANCE: invention relates to veterinary science. A method involves parenteral introduction of enrofloxacin to an affected animal. Enrofloxacin is dosed twice at most, and administered once a day for two following days in an amount 1 to 10 mg/kg a day.
EFFECT: method allows to simplify treatment of mastitis and provides higher clinical effectiveness.
11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENROFLOXACIN INJECTION OR INFUSION SOLUTION | 1995 |
|
RU2147225C1 |
| PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING MASTITES | 2013 |
|
RU2659430C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
| THERAPY OF RESPIRATORY APPARATUS BACTERIOSIS BY LOCAL APPLICATION OF FLUOROQUINOLONES | 2004 |
|
RU2373937C9 |
| NEW INJECTABLE COMPOSITIONS OF EPRINOMECTIN | 2011 |
|
RU2578036C2 |
| SODIUM CHLORIDE-CONTAINING MOXIFLOXACIN COMPOSITIONS | 2000 |
|
RU2260429C9 |
| NEW APPLICATION OF QUINOLONE ANTIBIOTICS | 2004 |
|
RU2367437C2 |
| INJECTION SOLUTION FOR TREATING VIRAL DISEASES SPECIFIED IN H1N1, H3N2, H5N1 INFLUENZA, TICK-BORNE ENCEPHALITIS AND WEST NILE FEVER | 2013 |
|
RU2574007C2 |
| INJECTABLE VETERINARY COMPOSITION | 2013 |
|
RU2641962C2 |
| AGENT FOR TREATMENT OF ENTERITIS IN ANIMALS | 2013 |
|
RU2554748C2 |
